12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)
Status:
Completed
Trial end date:
2015-08-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a second year of exposure to teriparatide in
both subjects that received a year of teriparatide or teriparatide-placebo will result in a
greater increase in bone mass density (BMD) compared to that seen in a single year's
treatment.
This study will also investigate 1) if a second year of teriparatide therapy will increase
bone strength in people with chronic spinal cord injury (SCI) who previously received a year
of teriparatide or teriparatide-placebo, 2) the number of participants with adverse events
from teriparatide, and 3) the effects of teriparatide on serum markers of bone metabolism.